↓ Skip to main content

Sentinel Lymph-Node Biopsy in Early-Stage Cervical Cancer: The 4-Year Follow-Up Results of the Senticol 2 Trial

Overview of attention for article published in Frontiers in oncology, February 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
33 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Sentinel Lymph-Node Biopsy in Early-Stage Cervical Cancer: The 4-Year Follow-Up Results of the Senticol 2 Trial
Published in
Frontiers in oncology, February 2021
DOI 10.3389/fonc.2020.621518
Pubmed ID
Authors

Guillaume Favre, Benedetta Guani, Vincent Balaya, Laurent Magaud, Fabrice Lecuru, Patrice Mathevet

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 33 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 12%
Other 3 9%
Student > Ph. D. Student 3 9%
Student > Bachelor 2 6%
Student > Doctoral Student 2 6%
Other 7 21%
Unknown 12 36%
Readers by discipline Count As %
Medicine and Dentistry 17 52%
Agricultural and Biological Sciences 1 3%
Unspecified 1 3%
Chemistry 1 3%
Economics, Econometrics and Finance 1 3%
Other 0 0%
Unknown 12 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 February 2021.
All research outputs
#18,003,904
of 26,338,415 outputs
Outputs from Frontiers in oncology
#8,354
of 22,976 outputs
Outputs of similar age
#293,271
of 460,826 outputs
Outputs of similar age from Frontiers in oncology
#396
of 976 outputs
Altmetric has tracked 26,338,415 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,976 research outputs from this source. They receive a mean Attention Score of 3.2. This one has gotten more attention than average, scoring higher than 57% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 460,826 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 976 others from the same source and published within six weeks on either side of this one. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.